In providing TP, BloodworksNW must also undertake a diagnostic review for each patient to determine whether the treatment meets nationally accepted criteria treatment for Hereditary Hemochromatosis. Another source for therapeutic phlebotomy will need to be found by the prescribing physician for these indications.įederal regulations and accreditation requirements of the College of American Pathologists require that all TP treatments be supported by a current order from an individual’s health care provider. The excluded categories are polycythemia vera, secondary polycythemia, and porphyria cutanea tarda. There will be no charge for the service.īloodworksNW’s is not able to bill for other categories of therapeutic phlebotomy and must discontinue service for these patients. These blood withdrawals need to be prescribed by their healthcare provider and will be reviewed by the Bloodworks medical director. All hereditary hemochromatosis patients capable of being drawn in our health care setting will be accepted for service.

We are going to include qualified potential donors with hereditary hemochromatosis in the blood supply using the requirements for this process for adding these voluntary blood donors to the community blood supply where it is permitted by FDA regulations (21 CFR 630) and professional standards. Bloodworks Northwest Program for Therapeutic Phlebotomy Patientsīloodworks Northwest Is updating its protocol and medical policies for people with conditions treated by blood collection - known as “therapeutic phlebotomy” (TP).

Hereditary by Jane Washington